Synonyms: Aesculin; Esculin; Esculin hydrate; 6,7-Dihydroxycoumarine-6-glucopyranoside; SC-15781; TL8003492; E0024; FT-0603455; N1766; 7-Hydroxycoumarin-6-yl beta-D-Glucopyranoside; C09264; 6-(.beta.-D-Glucopyranosyloxy)-7-hydroxy-cumarin; 6,7-dihydroxycoumarin 6-(beta-D-glucopyranoside);; 6,7-Dihydroxycoumarin-6-O-glucoside; SR-01000633930-1; SR-01000633930-3; BRD-K51742987-001-02-3; BRD-K51742987-002-02-1; Esculin, European Pharmacopoeia (EP) Reference Standard; 2H-1-Benzopyran-2-one,6-(b-D-glucopyranosyloxy)-7-hydroxy-; 6-(.beta.-D-Glucopyranosyloxy)-7-hydroxy-2H-1-benzopyran-2-one; 7-hydroxy-6-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-2H-chromen-2-one; 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one; 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-2-one; Aesculinum; 7-hydroxy-6-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2H-chromen-2-one; C15H16O9; ZINC04245693; Esculin hydrate, 98% - 25G 25g; ACN-035558; C15-H16-O9; CID5281417; CS-O-01441; A10044; D004929; Esculine; 2H-1-Benzopyran-2-one, 6-(.beta.-D-glucopyranosyloxy)-7-hydroxy-; 2H-1-Benzopyran-2-one, 6-(.beta.-D-glucopyranosyloxy)-7-hydroxy-, sesquihydrate; Esculetin 6-O-glucoside; 6,7-Dihydroxycoumarin 6-glucoside; UNII-1Y1L18LQAF; Esculetin 6-beta-D-glucoside; 6-(beta-D-Glucopyranosyloxy)-7-hydroxy-cumarin; 7-Hydroxy-6-cumarinyl-glucosid; Esculoside; 6-(beta-D-Glucopyranosyloxy)-7-hydroxy-2H-1-benzopyran-2-one; 1Y1L18LQAF; CHEBI:4853; XHCADAYNFIFUHF-TVKJYDDYSA-N; Aesculetin glukosid; 7-Hydroxy-6-glucosyloxy-2H-chromene; Esculin hydrate, 97%; Venoplant; Esculin sesquihydrate; MFCD00149492; Venoplant; Enallachrome; Bicolorin; Crataegin; Escosyl; Polychrom; 7-hydroxy-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2H-chromen-2-one; CCRIS 5724; 7-hydroxy-2-oxo-2H-chromen-6-yl beta-D-glucopyranoside; Vitamin C2; EINECS 208-517-5; Esculin; 7-Hydroxy-6-glucosyloxy-2H-chromen; NSC 26665; 66778-17-4; Esculina; 2H-1-Benzopyran-2-one, 6-(beta-D-glucopyranosyloxy)-7-hydroxy-; SR-01000633930; NSC-26665; esculetin glukosid; Aesculin(Esculin); NCGC00016491-01; aesculin; CAS-531-75-9; Aesculin (Esculin); Aesculin sesquihydrate; AC1NQYFK; Spectrum_000361; Spectrum2_000576; Spectrum3_000731; Spectrum4_001923; Spectrum5_000845; AC1Q77SX; 531-75-9; SCHEMBL2893; DSSTox_CID_25318; DSSTox_RID_80798; DSSTox_GSID_45318; Esculetin 6-|A-D-glucoside; BSPBio_002282; KBioGR_002266; KBioSS_000841; DivK1c_000956; SPECTRUM1500901; Esculoside; SPBio_000392; CHEMBL482581; DTXSID7045318; Esculetin-6-b-D-glucopyranoside; BCBcMAP01_000202; Esculetin 6-.beta.-D-glucoside; HMS502P18; KBio1_000956; KBio2_000841; KBio2_003409; (-)-Esculin; KBio2_005977; KBio3_001502; BIE3461; NINDS_000956; HMS1921M16; Esculetin-6-beta-D-glucopyranoside; ZINC3860441; Tox21_110453; CCG-38501; GC4131; Polychrome; MFCD00006879; s2258; AKOS015895151; AN-8433; DB13155; EBD2138591; MCULE-8058387809; SDCCGMLS-0066653.P001; IDI1_000956; SMP1_000008;